别名有，急性淋巴母细胞性白血病和急性淋巴性白血病。
Other names for ALL are acute lymphoblastic leukemia and acute lymphoid leukemia.
目的：研究大剂量甲氨蝶呤(HDMTX)治疗儿童急性淋巴性白血病的疗效。
Objective: To research about treatment of children ALL with high dose MTX and its therapeutic outcome.
研究结果显示儿童急性淋巴性白血病的生存机会的减少与工频电磁场辐照有很强的关联。
Results of the study show a significant association between power-frequency magnetic field exposure and reduced disease-free survival for children with acute lymphoblastic leukemia.
急性淋巴细胞性白血病是儿童最为常见的癌症，而且治疗能带来疾病治愈的好机会(译者：指治愈希望较大)。
Acute lymphocytic leukemia is the most common type of cancer in children, and treatments result in a good chance for a cure.
急性淋巴细胞性白血病(all)是一种发生于血液和骨髓的癌症——骨髓(译者：此处指红骨髓)是指作为造血场所的骨内的海绵组织。
Acute lymphocytic leukemia (ALL) is a type of cancer of the blood and bone marrow - the spongy tissue inside bones where blood cells are made.
急性淋巴细胞白血病和急性粒细胞性白血病均由癌变的母细胞引起，如淋巴母细胞或原始粒细胞。
Acute lymphocytic leukemia and acute myelogenous leukemia are each composed of blast cells, known as lymphoblasts or myeloblasts.
相对于急性白血病，慢性淋巴细胞白血病和慢性粒细胞性白血病通常进展缓慢。
Chronic lymphocytic leukemia and chronic myelogenous leukemia usually progress slowly compared to acute leukemias.
急性淋巴细胞性白血病也称急性淋巴母细胞性白血病，又称急性儿童期白血病。
Acute lymphocytic leukemia is also known as acute lymphoblastic leukemia and acute childhood leukemia.
氯法拉滨注射液适用于对至少2种治疗方案无效的儿童(1 - 21岁)难治性或复发性急性淋巴细胞白血病的治疗。
Clofarabine injection is indicated for the treatment of pediatric patients (ages 1-21 years) with relapsed or refractory acute lymphoblastic leukemia after at least 2 previous regimens.
目的研究急性淋巴细胞性白血病(all)免疫表型的特点。
Objective To study the character of immunophenotype in acute lymphoblastic leukemia (ALL).
系急性淋巴细胞性白血病(all)为出现于儿童与青少年的最常见的癌症。
B-lineage acute lymphoblastic leukemia (ALL) is the most common cancer occurring in children and adolescents.
目的研究急性淋巴细胞性白血病(all)中免疫表型的特点。
Objective To study the feature of immunophenotype in acute lymphoblastic leukemia (ALL).
目的：探讨我院急性非淋巴细胞性白血病(ANLL)患者的治疗效果及其预后相关因素。
Objective: to investigated the therapy effect and prognosis related factors in the Acute Non-lymphocytic leukemia (ANLL) patients.
在急性髓细胞性白血病aml和急性淋巴细胞性白血病all中，原始的急性白血病细胞进展、形成多达上亿个的白血病细胞。
In acute myelogenous leukemia (AML) and acute lymphocytic leukemia (ALL), the original acute leukemia cell goes on to form about a trillion more leukemia cells.
用单克隆抗体55,79检查了普通型急性淋巴细胞性白血病抗原(CALLA)的组织分布特点。
The tissue distribution of common acute lymphoblastic leukaemia antigen (CALLA) was detected by monoclonal antibodies 55, 79.
凝集试验表明PNA能凝集NA处理的红细胞、胸腺细胞及急性淋巴细胞性白血病细胞；
The agglutination test showed that PNA agglutinates neuraminidase-treated erythrocytes, thymocytes, and acute lymphatic leukemia cells.
目的：为提高急性非淋巴细胞性白血病(急非淋)的疗效。
Objective To improve the therapeutic effect of acute non-lymphatic leukemia (ANLL).
目的：通过血药浓度监测，提高对小儿急性淋巴细胞白血病大剂量甲氨蝶呤化疗的有效性和安全性。
OBJECTIVE: to improve the efficacy and safety of high dose methotrexate (HDMTX) chemotherapy in the treatment of children with acute lymphoblastic leukemia through blood concentration monitoring.
目的探讨CYP1A1基因多态性与急性淋巴细胞白血病（ALL）遗传易感性的关系。
Objective: To study the possible relationship between CYP1A1 genetic polymorphisms and susceptibility of acute lymphoblastic leukemia(ALL).
目的检测儿童急性淋巴细胞白血病细胞增殖性抗原表达情况，观察其与预后的关系。
Objective To study the expression of proliferative antigens in leukemic cells and the relationship between the cell proliferation activity and the prognosis.
目的：分析T细胞-急性淋巴细胞白血病(T -ALL)病人的T细胞克隆性。
AIM: To analyze t cell clonality in patients with t cell acute lymphoblastic leukemia (T-ALL).
它曾被报告与淋巴母细胞转变相关的急性骨髓性白血病、骨髓增生性疾病、脊髓发育不全症等等，甚至于那些不具已知的血液学异常相关的病人们身上。
It has been reported in association with acute myeloid leukemia, myeloproliferative disorders, and myelodysplasia in blast transformation, as well as in patients with no known hematological disorders.
目的探讨大剂量甲氨蝶呤(HD -MTX)治疗急性淋巴细胞白血病(all)在基层医院的可行性。
Objective To discuss the practicability of high-dose methotrexate (HD-MTX) in treatment of acute lymphoblastic leukemia (ALL) in children in basic-level hospitals.
急性淋巴细胞性白血病是儿童最常见的恶性肿瘤之一也是可治愈的恶性肿瘤之一。
EUSA Pharma said acute lymphoblastic leukemia is the most common form of childhood cancer and one of the most curable types.
目的通过糖皮质激素早期诱导试验评估儿童急性淋巴细胞性白血病的预后。
Objective To predict the prognosis of children acute lymphoblastic leukemia (ALL) by using glucocorticosteroid induction test.
目的探讨急性淋巴细胞白血病（ALL ，急淋）患儿化疗期全身性炎症反应综合征（SIRS）的发生、发展与预后的关系。
Objective To investigate the relationship of systemic inflammatory response syndrome(SIRS) and prognosis in children of acute lymphoblastic leukemia(ALL) during chemotherapy.
目的：总结湘雅医院近年住院治疗儿童急性淋巴细胞性白血病(all)临床资料，探讨影响儿童all长期无病生存(DFS)的因素。
Objective: to analyse the treatment outcome of childhood acute lymphoblastic leukemia (ALL) patients in our hospital, and explore the factors influencing the Disease-free survival (DFS).
病例二为10岁女孩，罹患慢性骨髓性白血病并急性淋巴球白血病危象。
The other case was a 10-year-old girl with the diagnosis of chronic leukemia with acute blastic crisis.
目的总结儿童急性淋巴细胞性白血病治疗后的脑mri表现。
Objective To summarize the MRI abnormalities seen in the brain after treatment of childhood acute lymphoblastic leukemia.
目的总结儿童急性淋巴细胞性白血病治疗后的脑mri表现。
Objective To summarize the MRI abnormalities seen in the brain after treatment of childhood acute lymphoblastic leukemia.
应用推荐